• S7:E3 – Morning Commute Podcast: Worth the Risk? Using Anti-Amyloid Therapies for Alzheimer’s Disease

  • Dec 15 2023
  • Length: 28 mins
  • Podcast
S7:E3 – Morning Commute Podcast: Worth the Risk? Using Anti-Amyloid Therapies for Alzheimer’s Disease By cover art

S7:E3 – Morning Commute Podcast: Worth the Risk? Using Anti-Amyloid Therapies for Alzheimer’s Disease

Listen for free

View show details

  • Summary

  • In this episode our faculty take a look at the treatment-related side effects associated with some of the newer treatments for Alzheimer’s disease, with a focus on amyloid-related imaging abnormalities (ARIA). How do you weigh the risk and benefits for your patients?

    Visit www.morningcommutepodcast.com/alzheimers3 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit.
    Show more Show less
Show more Show less

What listeners say about S7:E3 – Morning Commute Podcast: Worth the Risk? Using Anti-Amyloid Therapies for Alzheimer’s Disease

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available